Obesity in Children Clinical Trials

Find Obesity in Children Clinical Trials Near You

Impact of Weight Loss Interventions on Multiorgan Health, Detected by Quantitative MRI, in Children and Young People With Severe Obesity.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this study is to quantify the body composition and organ fat distribution changes with obesity interventions in adolescents with severe obesity. The main question the investigators aim to answer is if there is improvement in organ health with weight loss intervention. The investigators will be comparing the degree of these changes between children being treated with GLP1 receptor agonists in addition to lifestyle changes and those managed with lifestyle changes alone. Participants will undergo MRI body composition at baseline and after 9 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 18
Healthy Volunteers: f
View:

• Age 12 to \<18 years at the time of enrolment

• BMI \>99.6th centile or \>2.67 SDS

• Informed consent from parent(s) (or person with parental responsibility) and assent from the child or young person for participants aged less than 16 years (or)

• Informed consent from the participant if aged ≥ 16 years.

Locations
Other Locations
United Kingdom
Alder Hey Children's hospital
RECRUITING
Liverpool
Contact Information
Primary
Anand Ramakrishnan, MD (Ped), MSc (Diab), PhD endo
senthil.senniappan@alderhey.nhs.uk
+44 01512525956
Backup
Anand Ramakrishnan, MBBS, MD, MRCPCH, DipUKMP
anand.ramakrishnan@alderhey.nsh.uk
07404613764
Time Frame
Start Date: 2026-03-06
Estimated Completion Date: 2028-01
Participants
Target number of participants: 30
Treatments
Patients on GLP1 receptor agonist
Patients being treated with GLP1 receptor agonist in addition to lifestyle interventions
Patients not on GLP1 receptor agonist
Patients not being treated with GLP1 receptor agonist and only on lifestyle intervention
Related Therapeutic Areas
Sponsors
Leads: Alder Hey Children's NHS Foundation Trust

This content was sourced from clinicaltrials.gov